Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
-2.3%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$25B
AUM Growth
-$1.57B
(-5.9%)
Cap. Flow
-$922M
Cap. Flow
% of AUM
-3.69%
Top 10 Holdings %
Top 10 Hldgs %
22.22%
Holding
695
New
157
Increased
139
Reduced
161
Closed
203
Top Buys
| 1 |
Amazon
AMZN
|
+$494M |
| 2 |
Microsoft
MSFT
|
+$376M |
| 3 |
Salesforce
CRM
|
+$265M |
| 4 |
Electronic Arts
EA
|
+$225M |
| 5 |
AT&T
T
|
+$217M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$833M |
| 2 |
Alibaba
BABA
|
+$479M |
| 3 |
Meta Platforms (Facebook)
META
|
+$398M |
| 4 |
Boeing
BA
|
+$328M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$321M |
Sector Composition
| 1 | Technology | 21.48% |
| 2 | Consumer Discretionary | 12.61% |
| 3 | Healthcare | 10.38% |
| 4 | Industrials | 10.15% |
| 5 | Real Estate | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
UBX
476
DELISTED
Unity Biotechnology
UBX
| $304K | ﹤0.01% |
292,091
-566,992
| -66% | -$590K |
|
477
Roku
ROKU
$14.6B
| $302K | ﹤0.01% |
+4,281
| New | +$302K |
|
|
ARTV
478
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$75.5M
| $300K | ﹤0.01% |
100,000
| – | – |
|
479
Akebia Therapeutics
AKBA
$830M
| $258K | ﹤0.01% |
+134,277
| New | +$258K |
|
480
Werewolf Therapeutics
HOWL
$61.7M
| $229K | ﹤0.01% |
235,705
| – | – |
|
481
Nautilus Biotechnolgy
NAUT
$88.5M
| $218K | ﹤0.01% |
253,468
| – | – |
|
|
ALDFU
482
Aldel Financial II Inc. Units
ALDFU
$227M
| $213K | ﹤0.01% |
+20,757
| New | +$213K |
|
|
SEPN
483
Septerna, Inc. Common Stock
SEPN
$643M
| $203K | ﹤0.01% |
35,000
| – | – |
|
484
Rocket Pharmaceuticals
RCKT
$352M
| $202K | ﹤0.01% |
30,312
| – | – |
|
485
Traws Pharma
TRAW
$13.1M
| $121K | ﹤0.01% |
52,630
-64,084
| -55% | -$147K |
|
486
Surrozen
SRZN
$105M
| $119K | ﹤0.01% |
10,188
| – | – |
|
487
MDxHealth
MDXH
$176M
| $99.8K | ﹤0.01% |
70,293
-936,707
| -93% | -$1.33M |
|
488
InflaRx
IFRX
$107M
| $13.8K | ﹤0.01% |
+13,538
| New | +$13.8K |
|
489
Oracle
ORCL
$670B
| – | – |
-113,899
| Closed | -$19M |
|
490
Orion Group Holdings
ORN
$293M
| – | – |
-500,000
| Closed | -$3.67M |
|
|
OTLY
491
Oatly Group
OTLY
$531M
| – | – |
-18,484
| Closed | -$245K |
|
492
Occidental Petroleum
OXY
$44.7B
| – | – |
-951,059
| Closed | -$47M |
|
493
PG&E
PCG
$32B
| – | – |
-200,000
| Closed | -$4.04M |
|
494
Perion Network
PERI
$416M
| – | – |
-1,000,000
| Closed | -$8.47M |
|
495
PennyMac Financial
PFSI
$6.26B
| – | – |
-98,162
| Closed | -$10M |
|
496
Progressive
PGR
$144B
| – | – |
-125,358
| Closed | -$30M |
|
497
Parker-Hannifin
PH
$96.3B
| – | – |
-85,013
| Closed | -$54.1M |
|
498
Pinterest
PINS
$25.8B
| – | – |
-339,707
| Closed | -$9.85M |
|
499
Packaging Corp of America
PKG
$19.4B
| – | – |
-29,787
| Closed | -$6.71M |
|
500
Privia Health
PRVA
$2.9B
| – | – |
-300,000
| Closed | -$5.87M |
|